News Feed
HOME
News Feed
正文内容
A private enterprise in progress丨Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd.: technological innovation to create a leading brand of pet medicine
发布时间 : 2023-12-18
作者 : jumbo
访问数量 : 35
扫码分享至微信

Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd. regards technological innovation as the source of enterprise development, increases investment in R&D, improves the R&D system, and continuously increases its pet vaccine market share with core technology advantages and first-mover advantages in the industry. Rate.

Baodi Media

Private enterprises in progress丨Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd.: Scientific and technological innovation creates pet medicine Leading brand

Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd. is located in Zhongguancun Science and Technology City, Beijing and Tianjin. It is a company specializing in biological products and vaccines for pets. A national high-tech enterprise with R&D, production and sales. At present, the recombinant canine alpha interferon product independently developed by the company has been officially put into production, breaking through the stuck technology of biomedical products for canine viral diseases in my country.

He Ping, manager of the R&D Department of Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd., said:

In recent years, Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd. has relied on technology to Advantages, brand advantages and team advantages, every year 20% of sales are used for technology research and development of high-end products to improve product added value and the company's core competitiveness. At present, the company has 25 patents and 3 invention patents.

At the same time, they continue to expand regulations and capabilities to promote new products to be launched faster. At present, the Mao Sanlian production line with a total investment of more than 40 million yuan is undergoing equipment debugging and installation, and is expected to be put into production in January 2024.

Sun Yandong, deputy general manager of Zhongkebaike (Tianjin) Biopharmaceutical Co., Ltd., said:

A private enterprise in progress丨Zhongkebaike Ke (Tianjin) Biopharmaceutical Co., Ltd.: Scientific and technological innovation creates a leading brand of pet medicine

From settling in Baodi in 2019, to building a comprehensive recombinant cytokine free A modern GMP production base for veterinary biological products with multiple production lines, production plants, public works and other supporting facilities, Zhongkebaike (Tianjin) Biopharmaceuticals Co., Ltd. took root in Baodi and developed rapidly.

发布评论

Manager Wang: 180-0000-0000 (wechat same number)
sunny@jumbopet.net
Floor 29, Zhongmin University Xiamen, Hubin Middle Road, Siming District, Xiamen City
©2024  JUMBO  版权所有.All Rights Reserved.  
网站首页
电话咨询
微信号

QQ

在线咨询真诚为您提供专业解答服务

热线

15280250568
专属服务热线

微信

二维码扫一扫微信交流
顶部